EVRY ASA:企業の戦略・SWOT・財務情報

◆英語タイトル:EVRY ASA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C7634
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

EVRY ASA – Strategy, SWOT and Corporate Finance Report
Summary

EVRY ASA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

EVRY ASA (EVRY or ‘the company’) provides IT services in the Nordic region. The company’s service portfolio comprises of BI and analytics, digital transformation, cloud services, enterprise applications, infrastructure and operations, and workspace. EVRY also provides application management, systems development, test management and portfolio management. It provides SAP, Microsoft, Oracle and IBM technology with consulting services. EVRY caters to industries including municipalities, oil and gas, financial institutions, healthcare sectors. The company offers its presence across Ukraine, India, Finland, Denmark, Norway, Sweden and the UK. The company is headquartered in Oslo, Norway.

Scope

- Detailed information on EVRY ASA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting EVRY ASA in the form of a SWOT analysis
- An in-depth view of the business model of EVRY ASA including a breakdown and examination of key business segments
- Intelligence on EVRY ASA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about EVRY ASA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of EVRY ASA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess EVRY ASA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on EVRY ASA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
EVRY ASA: Company Overview 9
EVRY ASA: Overview and Key Facts 9
EVRY ASA: Overview 9
EVRY ASA: Key Facts 9
EVRY ASA: Key Employees 10
EVRY ASA: Key Employee Biographies 12
EVRY ASA: Major Products and Services 17
EVRY ASA: Company History 18
EVRY ASA: Management Statement 26
EVRY ASA: Locations and Subsidiaries 28
EVRY ASA: Key Competitors 29
EVRY ASA: Company Analysis 30
EVRY ASA: Business Description 30
EVRY ASA: SWOT Analysis 31
EVRY ASA: SWOT Overview 31
EVRY ASA: Strengths 31
EVRY ASA: Weaknesses 32
EVRY ASA: Opportunities 32
EVRY ASA: Threats 33
EVRY ASA: Corporate Financial Deals Activity 34
EVRY ASA: Financial Deals Overview 34
EVRY ASA: Targets and Partners 36
EVRY ASA: Top Deals 2014 – 2018YTD* 37
EVRY ASA: Advisors 38
EVRY ASA: Top Legal Advisors 38
EVRY ASA: Top Financial Advisors 38
EVRY ASA: Mergers and Acquisitions 39
EVRY ASA: Private Equity and Ownership 40
EVRY ASA: Recent Developments 41
EVRY ASA: News and Events Summary 41
EVRY ASA: Business Expansion 45
EVRY ASA: Contracts 45
EVRY ASA: Corporate Governance 47
EVRY ASA: Financial Deals 47
EVRY ASA: Financial Performance 48
EVRY ASA: Strategy and Operations 48
Appendix 49
Contact Us 49
Methodology 49
About MarketLine 50

List of Tables
Table 1: EVRY ASA: Key Facts
Table 2: EVRY ASA: Key Employees
Table 3: EVRY ASA: Company History
Table 4: EVRY ASA: Locations and Subsidiaries
Table 5: EVRY ASA: Key Competitors
Table 6: EVRY ASA: Deal Activity by Deal Type - Volume (TTM*)
Table 7: EVRY ASA: M&A Activity by Geography (TTM*)
Table 8: EVRY ASA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: EVRY ASA: Targets and Partners
Table 10: EVRY ASA: Top Deals 2014 - 2018YTD*
Table 11: EVRY ASA: Legal Advisor Ranking by Value (US$m)
Table 12: EVRY ASA: Financial Advisor Ranking by Value (US$m)
Table 13: EVRY ASA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: EVRY ASA: M&A Activity by Geography (2014 - YTD*2018)
Table 15: EVRY ASA: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 16: EVRY ASA: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 17: EVRY ASA: News and Events Summary
Table 18: EVRY ASA: Business Expansion
Table 19: EVRY ASA: Contracts
Table 20: EVRY ASA: Corporate Governance
Table 21: EVRY ASA: Financial Deals
Table 22: EVRY ASA: Financial Performance
Table 23: EVRY ASA: Strategy and Operations

List of Figures
Figure 1: EVRY ASA: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: EVRY ASA: M&A Activity by Geography (TTM*)
Figure 3: EVRY ASA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: EVRY ASA: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: EVRY ASA: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: EVRY ASA: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 7: EVRY ASA: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[EVRY ASA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nightingale Informatix Corp (NGH)-医療機器分野:企業M&A・提携分析
    Summary Nightingale Informatix Corp (Nightingale) is a healthcare technology company that develops, markets and licenses application software and related services. The company offers practice management, billing solutions, medical records and interoperability products. It provides web based document …
  • Lamprell Plc (LAM):石油・ガス:M&Aディール及び事業提携情報
    Summary Lamprell Plc (Lamprell) is an oil and gas company that provides offshore industry services. The company's business activities comprise construction of new build jackup drilling rigs, construction projects for the offshore oil and gas industry, engineering and construction, renewable and mult …
  • Sanofi India Ltd (SANOFI):企業の財務・戦略的SWOT分析
    Summary Sanofi India Ltd (Sanofi India), formerly Aventis Pharma Ltd, a subsidiary of Sanofi is a healthcare company that manufactures and markets pharmaceutical and prescription products. The company offers products in the form of capsules, tablets, insulin, injection, creams and gels, and solution …
  • Pacgen Life Science Corp (PBS):企業の財務・戦略的SWOT分析
    Summary Pacgen Life Science Corp (Pacgen), formerly Pacgen Biopharmaceuticals Corp, is a life science technology company that develops and commercializes biomedical products and services. The company offers development of novel therapeutic drug candidates. It provides product such as include amino-a …
  • Fluidigm Corp (FLDM)-医療機器分野:企業M&A・提携分析
    Summary Fluidigm Corp (Fluidigm) formerly known as Mycometrix Corporation, is a biotechnology company which manufactures life-science tools and creates technologies based on microfluidics and mass cytometry. The company’s products systems include biomark HD system, access array system, C1 system, ca …
  • Surgutneftegas (SNGS):企業の財務・戦略的SWOT分析
    Surgutneftegas (SNGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Xiangxue Pharmaceutical Co Ltd (300147):製薬・医療:M&Aディール及び事業提携情報
    Summary Xiangxue Pharmaceutical Co Ltd (XPH) is a pharmaceutical company that manufactures and distributes drugs and medicines. The company’s products include drugs, Chinese medicine pieces, medical instruments, health products and medicinal drinks, among others. It also provides healthcare suppleme …
  • Bioneer Corp (064550):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioneer Corp (Bioneer) is a molecular diagnostic company that develops and produces molecular research and molecular diagnostic products and instruments. The company’s major molecular research products include DNA/RNA amplification pre mixes, DNA/RNA preparation system, oligo synthesis and r …
  • Vitasoy International Holdings Limited (345):企業の財務・戦略的SWOT分析
    Vitasoy International Holdings Limited (345) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Takeuchi Mfg. Co Ltd
    Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Intercept Pharmaceuticals Inc (ICPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Intercept Pharmaceuticals Inc (Intercept) is a biopharmaceutical company that researches, develops and commercializes treatments for non-viral, progressive liver diseases. It develops products using its proprietary bile acid chemistry. The company’s lead product candidate, obeticholic acid ( …
  • Silver Peak Systems Inc:企業の戦略的SWOT分析
    Silver Peak Systems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • S.A. Industrias Celulosa Aragonesa:企業の戦略・SWOT・財務情報
    S.A. Industrias Celulosa Aragonesa - Strategy, SWOT and Corporate Finance Report Summary S.A. Industrias Celulosa Aragonesa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Suzlon Energy Limited:企業の戦略・SWOT・財務分析
    Suzlon Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Suzlon Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Neonc Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NeOnc Technologies Inc (NTI) is an early-stage cancer biotechnology company that focuses on the development of intranasal inhalation and other non-invasive therapies for the treatment of malignant brain cancer, lung cancer and other brain cancers. The company’s product portfolio includes NEO …
  • The Blackstone Group LP:企業の戦略・SWOT・財務情報
    The Blackstone Group LP - Strategy, SWOT and Corporate Finance Report Summary The Blackstone Group LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • BayWa AG:戦略・SWOT・企業財務分析
    BayWa AG - Strategy, SWOT and Corporate Finance Report Summary BayWa AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Plantic Technologies Ltd:企業の戦略的SWOT分析
    Plantic Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • HSN Inc:企業の戦略的SWOT分析
    HSN Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Atara Biotherapeutics Inc (ATRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Atara Biotherapeutics Inc (Atara) is a biopharmaceutical company that develops T-cell based immunotherapies for the treatment of cancers, other autoimmune diseases, and severe viral infections. The company is evaluating its lead candidate tabelecleucel, formerly ATA129, in Phase 3 for the tr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆